Evidence map›Paper›PMID 12937274›Full record

ArticleMolecular biology of the cell2003

DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP.

Juneth Joaquin Partridge, Joseph Onofrio Lopreiato, Martin Latterich, Fred Eliezer Indig

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Golgi Structure and Function in Health, Stress, and Diseases.Results and problems in cell differentiation · 2019
    Review
  10. The role of ubiquitin-dependent segregase p97 (VCP or Cdc48) in chromatin dynamics after DNA double strand breaks.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2017
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. VCP gene variation predicts outcome of advanced non-small-cell lung cancer platinum-based chemotherapy.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Juneth Joaquin PartridgeLaboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Joseph Onofrio Lopreiato
Martin Latterich
Fred Eliezer Indig
National Institutes of Health · USSalk Institute for Biological Studies · US

Funding

NUCLEAR CELL CYCLE AND MITOTIC MEMBRANE FUNCTIONR01GM054729 · NIGMS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI WEI, JING · 1997 to 2001
$418k
NIGMS NIH HHS GM-54729
6 · The paper itself

Abstract

We report a novel nucleolar interaction between the AAA ATPase p97/VCP and the Werner protein (WRNp), a member of the RecQ helicase family. p97/VCP mediates several important cellular functions in eucaryotic cells, including membrane fusion of the endoplasmic reticulum and Golgi and ubiquitin-dependent protein degradation. Mutations in the WRN gene cause Werner syndrome, a genetic disorder characterized by premature onset of aging symptoms, a higher incidence of cancer, and a high susceptibility to DNA damage caused by topoisomerase inhibitors. We observed that both WRNp and valosin-containing protein (VCP) were present in the nucleoplasm and in nucleolar foci in mammalian cells and that WRNp and p97/VCP physically interacted in the nucleoli. Importantly, the nucleolar WRNp/VCP complex was dissociated by treatment with camptothecin, an inhibitor of topoisomerase I, whereas other WRNp-associated protein complexes, such as WRNp/Ku 80, were not dissociated by this drug. Because WRN syndrome cells are sensitive to topoisomerase inhibitors, these observations suggest that the VCP/WRNp interaction plays an important role in WRN biology. We propose a novel role for VCP in the DNA damage response pathway through modulation of WRNp availability.

Indexed as

Adenosine TriphosphatasesAnimalsAntigens, NuclearCamptothecinCell Cycle ProteinsCell NucleolusCells, CulturedCloning, MolecularDNA-Binding ProteinsDNA DamageDNA HelicasesDNA Topoisomerases, Type IEndoplasmic ReticulumExodeoxyribonucleasesFluorescent Antibody TechniqueGolgi ApparatusAdenosine TriphosphatasesAntigens, NuclearCamptothecinCell Cycle ProteinsDNA-Binding ProteinsDNA HelicasesDNA Topoisomerases, Type IExodeoxyribonucleasesKu AutoantigenRecQ HelicasesValosin Containing ProteinVCP protein, humanVcp protein, mouseWerner Syndrome HelicaseWRN protein, humanXRCC5 protein, humanXrcc6 protein, humanXrcc6 protein, mouse

Identifiers

PMID12937274
PMCPMC207013
OpenAlexW2061673254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.